Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI)

(2009) Alessandro Testori et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Significance of a Positive Nonsentinel Lymph Node in Cutaneous Melanoma

(2009) Amir A. Ghaferi et al.   ANNALS OF SURGICAL ONCOLOGY

Health Care System and Socioeconomic Factors Associated With Variance in Use of Sentinel Lymph Node Biopsy for Melanoma in the United States

(2009) Karl Y. Bilimoria et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel node biopsy and standard of care for melanoma

(2009) Charles M. Balch et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2–pT3)

(2008) Zbigniew I. Nowecki et al.   ANNALS OF SURGICAL ONCOLOGY

Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma

(2008) Charlotte Ariyan et al.   ANNALS OF SURGICAL ONCOLOGY

Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma

(2008) Jeffrey E. Gershenwald et al.   JOURNAL OF CLINICAL ONCOLOGY